trial

The Effect of Intranasal Administration of Oxytocin on Empathic Abilities.

NCTId NCT00813436
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Unknown
Enrollment 100 (estimated)
Sponsored by Shalvata Mental Health Center
Primary completion 2010-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Unknown
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2008-05
Primary completion
2010-01
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Oxytocin (also: syntocinon, pitocin)

Sponsors

Shalvata Mental Health CenterLead Sponsor
University of HaifaCollaborator

Investigators

2
Yechiel Levkovitz, MD, PhDPrincipal Investigator
Simone Shamay-Tsoory, MAStudy Director

Sites

1 total
Hod HaSharon, Israel

Linked catalysts

1
The Effect of Intranasal Administration of Oxytocin on Empathic Abilities. — primary completion2010-01

Facts & assertions

4 sourced
Enrollment
100
Phase
PHASE2
Primary Completion Date
2010-01
Status
UNKNOWN
relationships
The graph out of here
drug
Oxytocin (also: syntocinon, pitocin)
drug
lead_sponsor
Shalvata Mental Health Center
company
collaborator
University of Haifa
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Yechiel Levkovitz, MD, PhD
person
Simone Shamay-Tsoory, MA
person